DETAILED NOTES ON MBL77

Not all sufferers with CLL call for therapy. Irrespective of all modern improvements, the iwCLL even now endorses watchful observation for clients with asymptomatic disease.86 This suggestion is based on no less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).R